Joel M. Montgomery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joel M. Montgomery has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
- Christina F. Spiropoulou
Centers for Disease Control and Prevention
12 shared publications - Jessica R. Spengler
Centers for Disease Control and Prevention
7 shared publications - John David Klena
Viral Special Pathogens Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA
7 shared publications - Stephen R. Welch
Centers for Disease Control and Prevention
6 shared publications - Florine E. M. Scholte
Division of High-Consequence Pathogens and Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention (CDC) , Atlanta
5 shared publications - Katherine A. Davies
Centers for Disease Control and Prevention
5 shared publications
Latest Publications
- Open Access
- 6 September 2026
- Published by Elsevier in SSRN Electronic Journal
Determinants of Lassa virus resistance to the antiviral nucleoside 4′-fluorouridine
4′-fluorouridine (4′-FlU, also called EIDD-2749) is a nucleoside analog with broad-spectrum antiviral activity. To assess the potential for Lassa virus (LASV) to develop 4’-FlU resistance, we selected variants able to grow in the presence of this compound. We identified two coding changes in the polymerase gene, C1201S and N1315S, associated with growth in the presence of 4′-FlU and an approximately 9-fold increase in EC50. When introduced into the LASV minigenome, the C1201S substitution reduced susceptibility to 4′-FlU with a 3-fold increase in EC50 but was also associated with reduced minigenome replication. This loss in replicative fitness was reversed when C1201S was present in combination with the N1315S substitution. Both the C1201 and N1315 residues were found to be completely conserved across LASV clades and located proximal to the active site in the polymerase structure. These data contribute to the development of 4′-FlU and related polymerase inhibitors as potential antiviral therapies for LASV.
- 6 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDeterminants of Lassa virus resistance to the antiviral nucleoside 4′-fluorouridine
4′-fluorouridine (4′-FlU, also called EIDD-2749) is a nucleoside analog with broad-spectrum antiviral activity. To assess the potential for Lassa virus (LASV) to develop 4’-FlU resistance, we selected variants able to grow in the presence of this compound. We identified two coding changes in the polymerase gene, C1201S and N1315S, associated with growth in the presence of 4′-FlU and an approximately 9-fold increase in EC50. When introduced into the LASV minigenome, the C1201S substitution reduced susceptibility to 4′-FlU with a 3-fold increase in EC50 but was also associated with reduced minigenome replication. This loss in replicative fitness was reversed when C1201S was present in combination with the N1315S substitution. Both the C1201 and N1315 residues were found to be completely conserved across LASV clades and located proximal to the active site in the polymerase structure. These data contribute to the development of 4′-FlU and related polymerase inhibitors as potential antiviral therapies for LASV.
- 24 July 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1)
Longitudinal in vivo imaging reveals asynchronous, incomplete Nipah virus clearance with prolonged focal CNS involvement in IFNAR −/− mice
Nipah virus (NiV; Paramyxoviridae, Henipavirus) causes a broad clinical spectrum ranging from asymptomatic infection to severe respiratory and neurological illness [1]. Two genetically distinct str...
- 24 July 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1)
Longitudinal in vivo imaging reveals asynchronous, incomplete Nipah virus clearance with prolonged focal CNS involvement in IFNAR −/− mice
Nipah virus (NiV; Paramyxoviridae, Henipavirus) causes a broad clinical spectrum ranging from asymptomatic infection to severe respiratory and neurological illness [1]. Two genetically distinct str...
- Open Access
- 13 May 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (5) , e0007126
Development of a broad-lineage Lassa virus rapid diagnostic test informed by the WHO REASSURED framework
Lassa fever is a high-risk viral disease endemic to West Africa for which rapid and reliable diagnosis is essential for outbreak control. Here, we describe the development of a lateral flow-based rapid diagnostic test (RDT) targeting the Lassa virus nucleoprotein using newly generated monoclonal antibody pairs. The analytical performance of the assay was evaluated using human serum and plasma specimens as well as inactivated Lassa virus strains and compared with a commercially available antigen test. The final RDT (Pair 2; 1P-44-7/9B-28) demonstrated high analytical sensitivity and 100% specificity across 60 human samples and detected multiple genetically diverse Lassa virus strains, with lineage-dependent differences in analytical sensitivity. In direct analytical comparisons using recombinant antigen, the assay was approximately 64-fold more sensitive than the ReLASV Pan-Lassa Antigen Rapid Test. The RDT provides a rapid visual readout, remains stable at ambient temperatures, and is suitable for decentralized testing workflows, features aligned with key aspects of the World Health Organization (WHO) REASSURED framework. These results indicate that the developed RDT offers a robust and broadly reactive platform for Lassa virus antigen detection and has potential utility for surveillance and outbreak response in resource-limited settings. IMPORTANCE: Lassa fever remains a significant public health concern in West Africa, where diagnostic capacity is often limited in endemic regions. This study describes the development of a broad-lineage Lassa virus rapid diagnostic test informed by the World Health Organization (WHO) REASSURED framework. The assay demonstrates high analytical sensitivity and broad lineage coverage in a field-deployable format, supporting its potential utility for early case detection and decentralized surveillance in endemic settings.
- 13 May 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (5) , e0007126
Open AccessDevelopment of a broad-lineage Lassa virus rapid diagnostic test informed by the WHO REASSURED framework
Lassa fever is a high-risk viral disease endemic to West Africa for which rapid and reliable diagnosis is essential for outbreak control. Here, we describe the development of a lateral flow-based rapid diagnostic test (RDT) targeting the Lassa virus nucleoprotein using newly generated monoclonal antibody pairs. The analytical performance of the assay was evaluated using human serum and plasma specimens as well as inactivated Lassa virus strains and compared with a commercially available antigen test. The final RDT (Pair 2; 1P-44-7/9B-28) demonstrated high analytical sensitivity and 100% specificity across 60 human samples and detected multiple genetically diverse Lassa virus strains, with lineage-dependent differences in analytical sensitivity. In direct analytical comparisons using recombinant antigen, the assay was approximately 64-fold more sensitive than the ReLASV Pan-Lassa Antigen Rapid Test. The RDT provides a rapid visual readout, remains stable at ambient temperatures, and is suitable for decentralized testing workflows, features aligned with key aspects of the World Health Organization (WHO) REASSURED framework. These results indicate that the developed RDT offers a robust and broadly reactive platform for Lassa virus antigen detection and has potential utility for surveillance and outbreak response in resource-limited settings. IMPORTANCE: Lassa fever remains a significant public health concern in West Africa, where diagnostic capacity is often limited in endemic regions. This study describes the development of a broad-lineage Lassa virus rapid diagnostic test informed by the World Health Organization (WHO) REASSURED framework. The assay demonstrates high analytical sensitivity and broad lineage coverage in a field-deployable format, supporting its potential utility for early case detection and decentralized surveillance in endemic settings.
- Open Access
- 24 April 2026
- Published by Elsevier in Antiviral Research
- Vol. 250, 106420
Distinct respiratory and neurological disease phenotypes in lethal Nipah virus Malaysia versus Bangladesh infection in IFNAR knockout mice
- 24 April 2026
- Published by Elsevier in Antiviral Research
- Vol. 250, 106420
Open AccessDistinct respiratory and neurological disease phenotypes in lethal Nipah virus Malaysia versus Bangladesh infection in IFNAR knockout mice
- 7 April 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (4) , e0231925
Mapping the geodispersal and evolutionary dynamics of regional Nipah virus strain in Bangladesh
Nipah virus (NiV) is a zoonotic pathogen causing severe respiratory and neurological disease in humans, with high fatality rates, primarily transmitted from fruit bats to humans through bat-tainted raw date palm sap and fruits. NiV outbreaks have occurred almost annually across 34 of 64 districts in Bangladesh. The study investigated the geodispersal patterns and evolutionary phylodynamics of NiV, aiding in more effective outbreak management strategies in Bangladesh. Phylodynamic and geographic evolutionary analyses were conducted using the nucleoprotein (N) gene sequence ( n = 23) isolated from human and bat samples (2016–2023), along with publicly available NiV genomes up through November 2024. Bayesian evolutionary analysis of NiV spatiotemporal data suggested NiV clade expansion and the emergence of a new lineage, possibly driven by genetic mutations over time, and identified potential risk areas for NiV infections. The analysis revealed that Bangladeshi NiV strains diverged into two major lineages, BD-1 and BD-2, around 1984. BD-1 is split into NiV-BD1.1 and BD1.2 (first detected in 2004), while BD-2 emerged in 2008, later diverging into BD2.1 and BD2.2. As of 2023, most bat-derived NiV sequences belong to the BD-2 lineage. The estimated evolutionary rate of NiV in Bangladesh is 4.89 × 10⁻⁴ substitutions/site/year (95% HPD: 3.71 × 10⁻⁴ – 6.45 × 10⁻⁴), with genetic clusters spanning from 6.54 km to 116.09 km. Our findings highlight ongoing evolution, the emergence of sub-lineages, and the geographic expansion of NiV in Bangladesh, underscoring the value of phylogeographic approaches in guiding targeted surveillance and control strategies. IMPORTANCE: A comprehensive understanding of the spread and evolution of the Nipah virus is critical, as it causes severe disease and frequent outbreaks in Bangladesh. This study provides a detailed look into how different strains of the Nipah virus have geographically moved and genetically changed over nearly two decades. By analyzing virus samples from fruit bats and infected human cases, the study reveals that the virus has formed two distinct sub-lineages, evolving separately at different times and regions of Bangladesh. Identifying these groups helps pinpoint areas most at risk for future outbreaks. These insights are important for identifying high-risk regions and informing surveillance priorities for early detection and preparedness, particularly in areas with recurring spillover events. Ultimately, this research emphasizes the importance of continuously monitoring Nipah virus evolution in both bats and humans, guiding public health strategies to manage and reduce the impact of this dangerous disease in Bangladesh and other regions.
- 7 April 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (4) , e0231925
Mapping the geodispersal and evolutionary dynamics of regional Nipah virus strain in Bangladesh
Nipah virus (NiV) is a zoonotic pathogen causing severe respiratory and neurological disease in humans, with high fatality rates, primarily transmitted from fruit bats to humans through bat-tainted raw date palm sap and fruits. NiV outbreaks have occurred almost annually across 34 of 64 districts in Bangladesh. The study investigated the geodispersal patterns and evolutionary phylodynamics of NiV, aiding in more effective outbreak management strategies in Bangladesh. Phylodynamic and geographic evolutionary analyses were conducted using the nucleoprotein (N) gene sequence ( n = 23) isolated from human and bat samples (2016–2023), along with publicly available NiV genomes up through November 2024. Bayesian evolutionary analysis of NiV spatiotemporal data suggested NiV clade expansion and the emergence of a new lineage, possibly driven by genetic mutations over time, and identified potential risk areas for NiV infections. The analysis revealed that Bangladeshi NiV strains diverged into two major lineages, BD-1 and BD-2, around 1984. BD-1 is split into NiV-BD1.1 and BD1.2 (first detected in 2004), while BD-2 emerged in 2008, later diverging into BD2.1 and BD2.2. As of 2023, most bat-derived NiV sequences belong to the BD-2 lineage. The estimated evolutionary rate of NiV in Bangladesh is 4.89 × 10⁻⁴ substitutions/site/year (95% HPD: 3.71 × 10⁻⁴ – 6.45 × 10⁻⁴), with genetic clusters spanning from 6.54 km to 116.09 km. Our findings highlight ongoing evolution, the emergence of sub-lineages, and the geographic expansion of NiV in Bangladesh, underscoring the value of phylogeographic approaches in guiding targeted surveillance and control strategies. IMPORTANCE: A comprehensive understanding of the spread and evolution of the Nipah virus is critical, as it causes severe disease and frequent outbreaks in Bangladesh. This study provides a detailed look into how different strains of the Nipah virus have geographically moved and genetically changed over nearly two decades. By analyzing virus samples from fruit bats and infected human cases, the study reveals that the virus has formed two distinct sub-lineages, evolving separately at different times and regions of Bangladesh. Identifying these groups helps pinpoint areas most at risk for future outbreaks. These insights are important for identifying high-risk regions and informing surveillance priorities for early detection and preparedness, particularly in areas with recurring spillover events. Ultimately, this research emphasizes the importance of continuously monitoring Nipah virus evolution in both bats and humans, guiding public health strategies to manage and reduce the impact of this dangerous disease in Bangladesh and other regions.
- Open Access
- 2 April 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e84947
Social Media Promotion of Raw Date Palm Sap and Emerging Nipah Virus Transmission Risk in Bangladesh: Descriptive Analysis of Multisource Data
Background: Nipah virus (NiV) infection is considered one of the deadliest infectious diseases, with a case fatality rate of approximately 71%. In Bangladesh, the primary risk factor for NiV infection is the consumption of raw date palm sap (DPS) contaminated with excreta from fruit bats (ie, members of the Pteropodidae family). Recently, the increasing use of social media among Bangladeshi youth has enabled business groups to widely advertise and sell raw DPS. This increased access, combined with young people perceiving consumption of raw DPS as an “adventurous event,” may facilitate an increase in incidences of NiV infection. Objective: We aimed to explore and document data from social media regarding raw DPS advertisements and consumption. Furthermore, we aimed to investigate the commercial distribution of raw DPS across the country. Methods: The data were accessed from common social media platforms used in Bangladesh, including Facebook and YouTube, between November 10, 2023, and January 31, 2024. We considered this period to capture public opinions, discussions, and reported incidents during the peak harvesting and consumption season of DPS. While DPS harvesting continues until March, early monitoring is essential for identifying the emerging concerns related to NiV transmission. Extracted variables were post dates and times, source locations, types of sources and posts, provider details (eg, sellers and gachis ), post descriptions, user reactions, views, comments, and shares. Particular emphasis was placed on identifying the districts of both DPS suppliers and recipients. We used R version 4.3.2 and Stata version 15 for analyzing statistical data and QGIS for geographic data. Results: Of 556 social media posts, 361 (64.9%) were advertisements promoting raw DPS. Few DPS-related posts were associated with raising awareness about DPS consumption and NiV infection. In total, 473,724 people interacted with the social media posts. The identification of supplier and recipient districts revealed 14 source districts of raw DPS. The majority of raw DPS were distributed from Rajshahi, Naogaon, Rajbari, and Faridpur, which are among the most NiV-prone districts. During the data collection period, we observed an average of 996 (SD 377) liters of raw DPS sold per day from multiple gachhis (sap collectors) and sellers (vendors) in Rajshahi. Conclusions: The marketing of raw DPS through digital media platforms has increased customer interest, as evidenced by the notably high level of public engagement observed on this topic within the Bangladeshi social media context. Distributing raw DPS using digital platforms is a marketing tool that significantly increases the availability of raw DPS to previously hard-to-reach markets and potentially increases individuals’ exposure to NiV infection. This study recommends a multidisciplinary approach, which incorporates context-specific public health investigations, policymaking, and digital media surveillance to address emerging public health concerns.
- 2 April 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e84947
Open AccessSocial Media Promotion of Raw Date Palm Sap and Emerging Nipah Virus Transmission Risk in Bangladesh: Descriptive Analysis of Multisource Data
Background: Nipah virus (NiV) infection is considered one of the deadliest infectious diseases, with a case fatality rate of approximately 71%. In Bangladesh, the primary risk factor for NiV infection is the consumption of raw date palm sap (DPS) contaminated with excreta from fruit bats (ie, members of the Pteropodidae family). Recently, the increasing use of social media among Bangladeshi youth has enabled business groups to widely advertise and sell raw DPS. This increased access, combined with young people perceiving consumption of raw DPS as an “adventurous event,” may facilitate an increase in incidences of NiV infection. Objective: We aimed to explore and document data from social media regarding raw DPS advertisements and consumption. Furthermore, we aimed to investigate the commercial distribution of raw DPS across the country. Methods: The data were accessed from common social media platforms used in Bangladesh, including Facebook and YouTube, between November 10, 2023, and January 31, 2024. We considered this period to capture public opinions, discussions, and reported incidents during the peak harvesting and consumption season of DPS. While DPS harvesting continues until March, early monitoring is essential for identifying the emerging concerns related to NiV transmission. Extracted variables were post dates and times, source locations, types of sources and posts, provider details (eg, sellers and gachis ), post descriptions, user reactions, views, comments, and shares. Particular emphasis was placed on identifying the districts of both DPS suppliers and recipients. We used R version 4.3.2 and Stata version 15 for analyzing statistical data and QGIS for geographic data. Results: Of 556 social media posts, 361 (64.9%) were advertisements promoting raw DPS. Few DPS-related posts were associated with raising awareness about DPS consumption and NiV infection. In total, 473,724 people interacted with the social media posts. The identification of supplier and recipient districts revealed 14 source districts of raw DPS. The majority of raw DPS were distributed from Rajshahi, Naogaon, Rajbari, and Faridpur, which are among the most NiV-prone districts. During the data collection period, we observed an average of 996 (SD 377) liters of raw DPS sold per day from multiple gachhis (sap collectors) and sellers (vendors) in Rajshahi. Conclusions: The marketing of raw DPS through digital media platforms has increased customer interest, as evidenced by the notably high level of public engagement observed on this topic within the Bangladeshi social media context. Distributing raw DPS using digital platforms is a marketing tool that significantly increases the availability of raw DPS to previously hard-to-reach markets and potentially increases individuals’ exposure to NiV infection. This study recommends a multidisciplinary approach, which incorporates context-specific public health investigations, policymaking, and digital media surveillance to address emerging public health concerns.
- 11 March 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (3) , e0170925
Monoclonal IgM antibodies mediate potent complement neutralization by targeting cell-derived epitopes on enveloped viruses
When studying virus neutralization by specific antibodies of the adaptive immune response, serum heat treatment is a standard procedure done to eliminate any non-specific effects by the complement system. Although non-specific, innate immune responses such as these may be relevant in determining infection outcome. We observed extensive variation between negative control donors in their ability to neutralize Ebola virus and other enveloped viruses in the presence of complement. The effect was mediated by the classical pathway of complement activation, with serum IgM the main initiator in a manner that depended on the cell line that produced the virus. To identify the epitope, three monoclonal IgM antibodies were isolated after a neutralization screen and probed against arrayed glycans. The antibodies were found to bind ganglioside GM2, and the test virus was rendered refractory to anti-GM2 neutralization when propagated in the presence of an inhibitor of ganglioside synthesis. Gangliosides and other host membrane moieties are known to be carried by viruses and to aid entry to cells. The findings here suggest that under specific circumstances, such moieties incorporated in lipid envelopes of viruses can be recognized by potently neutralizing IgM antibodies present in the serum of immunologically naïve individuals. IMPORTANCE: Neutralization, that is, the ability to block infection in cell culture, remains the primary functional attribute of therapeutic antibodies and humoral immune responses against viruses. Beyond direct effects—such as preventing virus attachment to the cell—virus inactivation by antibody-mediated complement deposition or lysis is often considered a type of neutralization. Viral envelope glycoproteins are the main targets of neutralizing antibodies. However, because viruses obtain their membranes from cells in which they replicate, the membranes are known to contain cell-derived markers in addition to virally encoded proteins. Having observed marked individual variance in naïve serum donors’ ability to neutralize Ebola virus and other enveloped viruses, we sought to understand the mechanism. Three IgM monoclonals targeting a cell-derived epitope were isolated. The findings expand on the importance of cellular factors exposed on the virion membrane and suggest that they may be targets of potent antibody-mediated immune monitoring.
- 11 March 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (3) , e0170925
Monoclonal IgM antibodies mediate potent complement neutralization by targeting cell-derived epitopes on enveloped viruses
When studying virus neutralization by specific antibodies of the adaptive immune response, serum heat treatment is a standard procedure done to eliminate any non-specific effects by the complement system. Although non-specific, innate immune responses such as these may be relevant in determining infection outcome. We observed extensive variation between negative control donors in their ability to neutralize Ebola virus and other enveloped viruses in the presence of complement. The effect was mediated by the classical pathway of complement activation, with serum IgM the main initiator in a manner that depended on the cell line that produced the virus. To identify the epitope, three monoclonal IgM antibodies were isolated after a neutralization screen and probed against arrayed glycans. The antibodies were found to bind ganglioside GM2, and the test virus was rendered refractory to anti-GM2 neutralization when propagated in the presence of an inhibitor of ganglioside synthesis. Gangliosides and other host membrane moieties are known to be carried by viruses and to aid entry to cells. The findings here suggest that under specific circumstances, such moieties incorporated in lipid envelopes of viruses can be recognized by potently neutralizing IgM antibodies present in the serum of immunologically naïve individuals. IMPORTANCE: Neutralization, that is, the ability to block infection in cell culture, remains the primary functional attribute of therapeutic antibodies and humoral immune responses against viruses. Beyond direct effects—such as preventing virus attachment to the cell—virus inactivation by antibody-mediated complement deposition or lysis is often considered a type of neutralization. Viral envelope glycoproteins are the main targets of neutralizing antibodies. However, because viruses obtain their membranes from cells in which they replicate, the membranes are known to contain cell-derived markers in addition to virally encoded proteins. Having observed marked individual variance in naïve serum donors’ ability to neutralize Ebola virus and other enveloped viruses, we sought to understand the mechanism. Three IgM monoclonals targeting a cell-derived epitope were isolated. The findings expand on the importance of cellular factors exposed on the virion membrane and suggest that they may be targets of potent antibody-mediated immune monitoring.
- Open Access
- 1 January 2026
- Published by Wiley in Neurology Research International
- Vol. 2026 (1) , 2045508
Factors Predicting the Outcome in Patients With Acute Encephalitis Syndrome: A Retrospective Analysis of Surveillance Data in Bangladesh
Introduction: Acute encephalitis syndrome (AES) is a severe inflammatory condition affecting the central nervous system, frequently leading to significant morbidity and mortality. Despite advancements in diagnostic techniques, the etiology of AES remains unidentified in a substantial number of cases, particularly in low‐ and middle‐income countries like Bangladesh. Understanding factors that predict outcomes in AES patients is crucial for improving management strategies and patient outcomes. Methods: We used data from the Nipah surveillance in Bangladesh, analyzing patients admitted with AES to 11 surveillance hospitals across diverse geographical regions in Bangladesh from January 2021 to December 2023. Trained surveillance team members screened patients and collected data through face‐to‐face interviews using a structured questionnaire, and surveillance physicians made decisions on enrollment as an AES case. Bivariate and multivariable logistic regression analyses were used to identify predictors of mortality. Results: A total of 12,603 AES patients were included, of whom 2,759 (22%) died. Mortality rates varied significantly across different administrative divisions, with the highest rates observed in the Rangpur division. Increased age, female sex, and delayed hospital admission were associated with higher odds of mortality. Patients from divisions like Rangpur and those aged 60 or over had notably higher odds of mortality, with adjusted odds ratios of 2.55 and 4.22, respectively. Clinical factors such as high pulse rate, ronchi, difficulty breathing, altered mental status, stiff neck, paralysis, and unconsciousness at admission were significantly associated with unfavorable outcomes. Discussion: The findings highlight significant geographical, demographic, and clinical predictors of mortality among AES patients in Bangladesh. Older age, delayed hospital admission, and certain reported clinical symptoms on admission increase the risk of death. The study underscores the importance of timely intervention and targeted management strategies, particularly in identified aforementioned high‐risk groups. Conclusion: Identifying predictors of adverse outcomes in AES patients can aid in developing early warning and triage systems, potentially enabling adequate resource allocation and the delivery of timely, personalized, and higher standard of care.
- 1 January 2026
- Published by Wiley in Neurology Research International
- Vol. 2026 (1) , 2045508
Open AccessFactors Predicting the Outcome in Patients With Acute Encephalitis Syndrome: A Retrospective Analysis of Surveillance Data in Bangladesh
Introduction: Acute encephalitis syndrome (AES) is a severe inflammatory condition affecting the central nervous system, frequently leading to significant morbidity and mortality. Despite advancements in diagnostic techniques, the etiology of AES remains unidentified in a substantial number of cases, particularly in low‐ and middle‐income countries like Bangladesh. Understanding factors that predict outcomes in AES patients is crucial for improving management strategies and patient outcomes. Methods: We used data from the Nipah surveillance in Bangladesh, analyzing patients admitted with AES to 11 surveillance hospitals across diverse geographical regions in Bangladesh from January 2021 to December 2023. Trained surveillance team members screened patients and collected data through face‐to‐face interviews using a structured questionnaire, and surveillance physicians made decisions on enrollment as an AES case. Bivariate and multivariable logistic regression analyses were used to identify predictors of mortality. Results: A total of 12,603 AES patients were included, of whom 2,759 (22%) died. Mortality rates varied significantly across different administrative divisions, with the highest rates observed in the Rangpur division. Increased age, female sex, and delayed hospital admission were associated with higher odds of mortality. Patients from divisions like Rangpur and those aged 60 or over had notably higher odds of mortality, with adjusted odds ratios of 2.55 and 4.22, respectively. Clinical factors such as high pulse rate, ronchi, difficulty breathing, altered mental status, stiff neck, paralysis, and unconsciousness at admission were significantly associated with unfavorable outcomes. Discussion: The findings highlight significant geographical, demographic, and clinical predictors of mortality among AES patients in Bangladesh. Older age, delayed hospital admission, and certain reported clinical symptoms on admission increase the risk of death. The study underscores the importance of timely intervention and targeted management strategies, particularly in identified aforementioned high‐risk groups. Conclusion: Identifying predictors of adverse outcomes in AES patients can aid in developing early warning and triage systems, potentially enabling adequate resource allocation and the delivery of timely, personalized, and higher standard of care.
- 28 December 2025
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1) , 2595795
Crimean-Congo hemorrhagic fever virus localization and shedding in the reproductive tract of lethal and survivor mouse models
Hemorrhagic fever viruses have been shown to localize to immune-privileged sites, including the reproductive tract, raising important questions about long-term persistence and the potential for sexual transmission. Anecdotal evidence of sexual transmission of Crimean-Congo hemorrhagic fever virus (CCHFV) has been reported, and in vivo studies suggest that CCHFV can localize to reproductive tissues; however, to date, this phenomenon has not been explicitly investigated. We evaluated histopathology and viral loads (viral RNA, viral antigen, and infectious viral titers) in reproductive tissues obtained from lethal and survivor mouse models of CCHFV during acute and convalescent phases of infection. Viral loads in urogenital swabs were also evaluated to assess the potential for virus transmission. Although no evidence of long-term persistence was observed in the survivor model of CCHF, our data indicate a potential for sexual transmission during acute infection, even in cases of mild disease, as infectious virus was isolated from urogenital swabs. These data support the importance of sampling human patients to better define the risk of sexual transmission and potential viral persistence in reproductive tissues during and after recovery from CCHF.
- 28 December 2025
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1) , 2595795
Crimean-Congo hemorrhagic fever virus localization and shedding in the reproductive tract of lethal and survivor mouse models
Hemorrhagic fever viruses have been shown to localize to immune-privileged sites, including the reproductive tract, raising important questions about long-term persistence and the potential for sexual transmission. Anecdotal evidence of sexual transmission of Crimean-Congo hemorrhagic fever virus (CCHFV) has been reported, and in vivo studies suggest that CCHFV can localize to reproductive tissues; however, to date, this phenomenon has not been explicitly investigated. We evaluated histopathology and viral loads (viral RNA, viral antigen, and infectious viral titers) in reproductive tissues obtained from lethal and survivor mouse models of CCHFV during acute and convalescent phases of infection. Viral loads in urogenital swabs were also evaluated to assess the potential for virus transmission. Although no evidence of long-term persistence was observed in the survivor model of CCHF, our data indicate a potential for sexual transmission during acute infection, even in cases of mild disease, as infectious virus was isolated from urogenital swabs. These data support the importance of sampling human patients to better define the risk of sexual transmission and potential viral persistence in reproductive tissues during and after recovery from CCHF.
- Open Access
- 28 November 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 163, 108263
Insights into the acute phase of Nipah virus infection: Clinical features, viral detection, and humoral immune response
- 28 November 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 163, 108263
Open AccessInsights into the acute phase of Nipah virus infection: Clinical features, viral detection, and humoral immune response